(Q37801927)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964556%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

title

Implications of efavirenz for neuropsychiatry: a review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964556%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964556%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Danielle Macedo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964556%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

G I T Cavalcante

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964556%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

V L M Capistrano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964556%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

F S D Cavalcante

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964556%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

F C F Sousa

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964556%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

D J Woods

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964556%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

M M F Fonteles

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964556%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

22 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964556%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Neuroscience

15 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964556%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

volume

120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964556%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964556%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

page(s)

739-745

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964556%20AND%20SRC:MED&resulttype=core&format=json

The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteers

15 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Oxidative modification of creatine kinase BB in Alzheimer's disease brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Interactions between recreational drugs and antiretroviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Neuropsychiatric side effects of efavirenz therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Severe CNS side-effect and persistent high efavirenz plasma levels in a patient with HIV/HCV coinfection and liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Manic syndrome associated with efavirenz overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Antiviral drugs: current state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Abnormal properties of creatine kinase in Alzheimer's disease brain: correlation of reduced enzyme activity and active site photolabeling with aberrant cytosol-membrane partitioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Heme precursor 5-aminolevulinic acid alters brain tryptophan and serotonin levels without changing pineal serotonin and melatonin concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

An exploratory approach to the serotonergic hypothesis of depression: bridging the synaptic gap.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Long-term neuropsychiatric disorders on efavirenz-based approaches: quality of life, psychologic issues, and adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Role of 5-HT in stress, anxiety, and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Induction of CYP3A4 by efavirenz in primary human hepatocytes: comparison with rifampin and phenobarbital

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Comparison of neuropsychiatric side effects in an observational cohort of efavirenz- and protease inhibitor-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Adverse drug reactions to nonnucleoside reverse transcriptase inhibitor-based antiretroviral regimen: a 24-week prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Mitochondrial dysfunction in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Molecular evidence for mitochondrial dysfunction in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Inflammation and depression: is there a causal connection with dementia?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Efavirenz dose reduction to 200 mg once daily in a patient treated with rifampicin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

The cellular neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Efavirenz induces depressive-like behaviour, increased stress response and changes in the immune response in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Concurrent use of bupropion with CYP2B6 inhibitors, nelfinavir, ritonavir and efavirenz: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Safety and tolerance of efavirenz in different antiretroviral regimens: results from a national multicenter prospective study in 1,033 HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Management of sudden psychiatric disorders related to efavirenz

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

An update and review of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Central nervous system adverse effects with efavirenz: case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Effect of treatment with efavirenz on neuropsychiatric adverse events of interferon in HIV/HCV-coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Neuropsychiatric adverse effects of interferon-alpha: recognition and management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Efavirenz and chronic neuropsychiatric symptoms: a cross-sectional case control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Brain Serotonin1A Receptor Binding Measured by Positron Emission Tomography With [11C]WAY-100635

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Brain creatine kinase activity in an animal model of mania

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Effects of the HIV treatment drugs nevirapine and efavirenz on brain creatine kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Structural biology of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Therapeutic effects of nonnucleoside reverse transcriptase inhibitors on the central nervous system in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

Preliminary Data of a Prospective Study on Neuropsychiatric Side Effects After Initiation of Efavirenz

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F00207454.2010.520541

10.3109/00207454.2010.520541

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20964556%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference